Variable | MPR first tertile (≤1.34) (n = 39) | MPR second tertile (1.34−1.69) (n = 40) | MPR third tertile (≥1.69) (n = 40) | Total (n = 119) | P |
Age (y) | 68 ± 10 | 67 ± 12 | 66 ± 10 | 67 ± 11 | 0.52 |
Sex (F/M) (n) | 6/34 | 12/26 | 4/36 | 22/96 | 0.15 |
Hypercholesterolemia (%) | 50 | 50 | 35 | 45 | 0.31 |
Smoking (%) | 38 | 29 | 30 | 32 | 0.81 |
Diabetes mellitus (%) | 28 | 16 | 3 | 15 | 0.010 |
Hypertension (%) | 43 | 26 | 35 | 35 | 0.81 |
Family history (%) | 43 | 41 | 48 | 44 | 0.52 |
Previous myocardial infarction (%) | 85 | 79 | 78 | 81 | 0.97 |
Previous CABG (%) | 18 | 24 | 15 | 19 | 0.45 |
Previous PCI (%) | 58 | 63 | 35 | 62 | 0.65 |
LVEF (%) | 27 ± 12 | 34 ± 17 | 36 ± 13 | 32 ± 15 | 0.011 |
Typical anginal complaints (%) | 83 | 95 | 93 | 90 | 0.21 |
LVEDV (mL) | 186 ± 104 | 153 ± 91 | 120 ± 83 | 154 ± 96 | 0.007 |
Aspirin (%) | 58 | 61 | 78 | 65 | 0.095 |
Coumadin (%) | 40 | 40 | 20 | 33 | 0.078 |
Statin (%) | 45 | 47 | 35 | 42 | 0.349 |
Diuretic (%) | 35 | 37 | 23 | 31 | 0.332 |
Digoxin (%) | 20 | 8 | 0 | 9 | 0.007 |
β-blocker (%) | 78 | 71 | 78 | 75 | 0.59 |
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (%) | 53 | 58 | 45 | 52 | 0.53 |
Matching defect (% left ventricle) | 30 ± 13 | 27 ± 12 | 25 ± 16 | 27 ± 14 | 0.23 |
Mismatching defect (% left ventricle) | 15 ± 11 | 13 ± 12 | 11 ± 10 | 13 ± 11 | 0.34 |
Myocardial perfusion at rest (mL/min/100 g) | 94 ± 21 | 88 ± 25 | 89 ± 22 | 90 ± 22 | 0.29 |
Myocardial perfusion during stress (mL/min/100 g) | 110 ± 28 | 130 ± 38 | 177 ± 46 | 139 ± 47 | 0.0001 |
Categoric variables are shown as percentage (%) or as number (n), continuous variables as mean ± SD.